Gommeren, Kris ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Desmas, Isabelle ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Pathologie médicale des petits animaux
Garcia, Alexandra ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Département clinique des animaux de compagnie et des équidés
Clercx, Cécile ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Mc Entee, Kathleen ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Merveille, Anne-Christine ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Peeters, Dominique ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Médecine interne des animaux de compagnie
Language :
English
Title :
Cardiovascular biomarkers in dogs with systemic inflammatory response syndrome
de Laforcade AM. Systemic inflammatory response syndrome. In: Silverstein DC, Hopper K, eds. Small Animal Critical Care Medicine. 2nd ed. St. Louis, MO: Saunders Elsevier; 2015:31–34.
Hauptman JG, Walshaw R, Olivier NB. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg. 1997;26:393–397.
Parker M, Shelhamer J, Bacharach S, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100:483–490.
Werdan K, Schmidt H, Ebelt H, et al. Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol. 2009;87:266–274.
Levy R, Piel D, Acton P, et al. Evidence of myocardial hibernation in the septic heart. Crit Care Med. 2005;33:2752–2756.
Maeder M, Fehr T, Rickli H, et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest. 2006;129:1349–1366.
Natanson C, Fink M, Ballantyne H, et al. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest. 1986;78:259–270.
Marik P, Varon J. Sepsis: state of the art. Dis Mon. 2001;47:465–532.
Charpentier J, Luyt CE, Fulla Y, et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med. 2004;32:660–665.
Babuin L, Vasile V, Rio Perez J, et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med. 2008;36:759–765.
Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol. 2003;41:2004–2009.
Chen Y, Li C. Prognostic significance of brain natriuretic peptide obtained in the ED in patients with SIRS or sepsis. Am J Emerg Med. 2009;27:701–706.
Meyer B, Huelsmann M, Wexberg P, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med. 2007;35:2268–2273.
Rudiger A, Fischler M, Harpes P, et al. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts. Int J Cardiol. 2008;126:28–31.
Witthaut R, Busch C, Fraunberger P, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003;29:1696–1702.
Dickinson A, Rozanski E, Rush J. Reversible myocardial depression associated with sepsis in a dog. J Vet Intern Med. 2007;21:1117–1120.
Nelson O, Thompson P. Cardiovascular dysfunction in dogs associated with critical illnesses. J Am Anim Hosp Assoc. 2006;42:344–349.
Langhorn R, Persson F, Åblad B, et al. Myocardial injury in dogs with snake envenomation and its relation to systemic inflammation. J Vet Emerg Crit Care. 2014;24:174–181.
Hamacher L, Dorfelt R, Muller M, et al. Serum cardiac troponin I concentrations in dogs with systemic inflammatory response syndrome. J Vet Intern Med. 2015;29:164–170.
Langhorn R, Oyama MA, King LG, et al. Prognostic importance of myocardial injury in critically ill dogs with systemic inflammation. J Vet Intern Med. 2013;27:895–903.
Roch A, Allardet-Servent J, Michelet P, et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med. 2005;33:1001–1007.
Wang F, Wu Y, Tang L, et al. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis. Crit Care. 2012;16:R74.
Spies C, Haude V, Fitzner R, et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest. 1998;113:1055–1063.
Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med. 1999;27:1775–1780.
Burgener IA, Kovacevic A, Mauldin GN, et al. Cardiac troponins as indicators of acute myocardial damage in dogs. J Vet Intern Med. 2006;20:277–283.
Schober KE, Cornand C, Kirbach B, et al. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc. 2002;221:381–388.
Schober KE, Kirbach B, Oechtering G. Noninvasive assessment of myocardial cell injury in dogs with suspected cardiac contusion. J Vet Cardiol. 1999;1:17–25.
Lobetti R, Dvir E, Pearson J. Cardiac troponins in canine babesiosis. J Vet Intern Med. 2002;16:63–68.
Diniz PP, de Morais HS, Breitschwerdt EB, et al. Serum cardiac troponin I concentration in dogs with ehrlichiosis. J Vet Intern Med. 2008;22:1136–1143.
Mastrorilli C, Dondi F, Agnoli C, et al. Clinicopathologic features and outcome predictors of Leptospira interrogans Australis serogroup infection in dogs: a retrospective study of 20 cases (2001-2004). J Vet Intern Med. 2007;21:3–10.
Silvestrini P, Piviani M, Alberola J, et al. Serum cardiac troponin I concentrations in dogs with leishmaniasis: correlation with age and clinicopathologic abnormalities. Vet Clin Pathol. 2012;41:568–574.
Lobetti R, Kirberger R, Keller N, et al. NT-ProBNP and cardiac troponin I in virulent canine babesiosis. Vet Parasitol. 2012;190:333–339.
Langhorn R, Thawley V, Oyama MA, et al. Prediction of long-term outcome by measurement of serum concentration of cardiac troponins in critically ill dogs with systemic inflammation. J Vet Intern Med. 2014;28:1492–1497.
Lee JA, Herndon WE, Rishniw M. The effect of noncardiac disease on plasma brain natriuretic peptide concentration in dogs. J Vet Emerg Crit Care. 2011;21:5–12.
Boswood A, Dukes-McEwan J, Loureiro J, et al. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract. 2008;49:26–32.
De Zoysa JR. Cardiac troponins and renal disease. Nephrology (Carlton). 2004;9:83–88.
Lamb EJ, Webb MC, Abbas NA. The significance of serum troponin T in patients with kidney disease: a review of the literature. Ann Clin Biochem. 2004;41:1–9.
Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant. 1998;13:1709–1712.
McCullough PA, Nowak RM, Foreback C, et al. Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. Acad Emerg Med. 2002;9:1389–1396.
McLaurin MD, Apple FS, Falahati A, et al. Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency. Am J Cardiol. 1998;82:973–975.
Rahman A, Broadley SA. Review article: elevated troponin: diagnostic gold or fool's gold? Emerg Med Australas. 2014;26:125–130.
Apple FS, Murakami MM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941–2945.
Ooi DS, Zimmerman D, Graham J, et al. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem. 2001;47:412–417.
Apple FS, Sharkey SW, Hoeft P, et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis. 1997;29:399–403.
Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349.
Stolear JC, Georges B, Shita A, et al. The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis. Nephrol Dial Transplant. 1999;14:1961–1967.
Osathanon R, Moonarmart W, Suksantilap N, et al. Evaluation of hematology profiles and measurement of serum cardiac troponin level in canine monocytic ehrlichiosis. Thai J Vet Med. 2013;43:405–409.
Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254–261.
DeFrancesco TC, Atkins CE, Keene BW, et al. Prospective clinical evaluation of serum cardiac troponin T in dogs admitted to a veterinary teaching hospital. J Vet Intern Med. 2002;16:553–557.
Fonfara S, Loureiro J, Swift S, et al. Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs. Vet J. 184:334–339.
Feng X, Taggart P, Hall L, et al. Limited additional release of cardiac troponin I and T in isoproterenol-treated beagle dogs with cardiac injury. Clin Chem. 2005;51:1305–1307.
Wu A. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med. 2001;27:959–961.
Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res. 2007;68:42–47.
Hori Y, Tsubaki M, Katou A, et al. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis. J Vet Intern Med. 2008;22:1118–1123.
Noszczyk-Nowak A. NT-pro-BNP and troponin I as predictors of mortality in dogs with heart failure. Pol J Vet Sci. 2011;14:551–556.
Fromm RJ, Varon J. NH2 terminal pro-brain natriuretic peptide in cardiovascular dysfunction and septic shock. Crit Care Med. 2005;33:1156–1157.
Wu TT, Yuan A, Chen CY, et al. Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction. Shock. 2004;22:95–101.
Prosek R, Sisson DD, Oyama MA, et al. Distinguishing cardiac and noncardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I. J Vet Intern Med. 2007;21:238–242.
Hagman R, Lagerstedt AS, Fransson BA, et al. Cardiac troponin I levels in canine pyometra. Acta Vet Scand. 2007;49:6.
Porciello F, Rishniw M, Herndon WE, et al. Cardiac troponin I is elevated in dogs and cats with azotaemia renal failure and in dogs with non-cardiac systemic disease. Aust Vet J. 2008;86:390–394.
Pelander L, Hagman R, Häggström J. Concentrations of cardiac troponin I before and after ovariohysterectomy in 46 female dogs with pyometra. Acta Vet Scand. 2008;50:35.
Barr S, Warner K, Kornreic B, et al. A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. Antimicrob Agents Chemother. 2005;49:5160–5161.
O'Brien PJ, Dameron GW, Beck ML, et al. Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sci. 1997;47:486–495.
Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991;67:1360–1367.
Phua J, Lim TK, Lee KH. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med. 2005;33:2094–2013.
Rau S, Kohn B, Richter C, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol. 2007;36:253–260.
Yu DH, Nho DH, Song RH, et al. High-mobility group box 1 as a surrogate prognostic marker in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care. 2010;20:298–302.
